Details for New Drug Application (NDA): 009078
✉ Email this page to a colleague
NDA 009078 describes PARSIDOL, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the PARSIDOL profile page.
The generic ingredient in PARSIDOL is ethopropazine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the ethopropazine hydrochloride profile page.
The generic ingredient in PARSIDOL is ethopropazine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the ethopropazine hydrochloride profile page.
Summary for 009078
| Tradename: | PARSIDOL |
| Applicant: | Parke Davis |
| Ingredient: | ethopropazine hydrochloride |
| Patents: | 0 |
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 006
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 008
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
